Posted on April 4th, 2009 by Health News
In patients who have suffered an acute MI and are receiving optimal medical care, omega-3 fatty acids–the kind found in oily fish–offer no additional benefits, according to the results of the OMEGA study. Heartwire
No Comments »
Filed under: General Health News
Posted on April 4th, 2009 by Health News
Zoll Medical Corp has launched a “field corrective action” on its AED Plus automated external defibrillators manufactured prior to February 12, 2009.
Heartwire
No Comments »
Filed under: General Health News
Posted on April 4th, 2009 by Health News
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version for Bayer Healthcare Pharmaceuticals’ oral contraceptive Yaz® (Drospirenone and Ethinyl Estradiol) Tablets. As the first company to file an ANDA containing a paragraph IV certification [...]
No Comments »
Filed under: Pharmacy News
Posted on April 4th, 2009 by Health News
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version for Bayer Healthcare Pharmaceuticals’ oral contraceptive Yaz® (Drospirenone and Ethinyl Estradiol) Tablets. As the first company to file an ANDA containing a paragraph IV certification [...]
No Comments »
Filed under: Pharmacy News
Posted on April 4th, 2009 by Health News
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version for Bayer Healthcare Pharmaceuticals’ oral contraceptive Yaz® (Drospirenone and Ethinyl Estradiol) Tablets. As the first company to file an ANDA containing a paragraph IV certification [...]
No Comments »
Filed under: Women's Health
Posted on April 4th, 2009 by Health News
Recent studies have questioned the wisdom of getting regular tests for prostate cancer. Tulane University School of Medicine prostate cancer expert Dr. Oliver Sartor is available to talk about the latest treatments for prostate cancer and who should continue to seek annual tests for the deadly cancer. Sartor is sought after by [...]
No Comments »
Filed under: Men's Health
Posted on April 4th, 2009 by Health News
Discovering new chemotherapy agents is one of the most difficult tasks in medicinal chemistry, and, given the deepening recession, resources are threatening to hit all-time lows. Of the thousands of active compounds synthesized, very few have progressed beyond early clinical development.
No Comments »
Filed under: Pharmacy News
Posted on April 4th, 2009 by Health News
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced that management will present an overview of the company’s three hepatitis C programs at the Canaccord Adams Hepatitis C Conference on Tuesday, April 7 at 9:45 a.m. ET at the InterContinental The Barclay New York Hotel in New York City. The live and archived webcasts [...]
No Comments »
Filed under: Pharmacy News
Posted on April 4th, 2009 by Health News
Roche announced that its new LightCycler(R) test for the detection of methicillin-resistant Staphylococcus aureus (MRSA) is now available with the CE Mark, allowing it to be sold for clinical use in the European Union. The LightCycler(R) MRSA Advanced Test is a qualitative in vitro diagnostic test for the direct detection of nasal colonization with methicillin-resistant [...]
No Comments »
Filed under: Pharmacy News
Posted on April 4th, 2009 by Health News
A newly discovered genetic abnormality that appears to prevent some men from conceiving children could be the key for developing a male contraceptive, according to University of Iowa researchers reporting their findings in the April 2 online edition of the American Journal of Human Genetics.
No Comments »
Filed under: Men's Health